Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route
Clinical trial NCT03845231 · COMPLETED
Trial details
- NCT number
- NCT03845231
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2019-12-20
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.